CSL Limited (ASX:CSL)
Australia · Delayed Price · Currency is AUD 216.45
+5.45 (2.58%)
Oct 15, 2025, 4:18 PM AEST
CSL Limited Market Cap
CSL Limited has a market cap or net worth of 104.62 billion as of October 15, 2025. Its market cap has decreased by -24.72% in one year.
Market Cap
104.62B
Enterprise Value
122.03B
Revenue
23.73B
Ranking
n/a
PE Ratio
23.00
Stock Price
216.45
Market Cap Chart
Since June 2, 1994, CSL Limited's market cap has increased from 312.00M to 104.62B, an increase of 33,432.33%. That is a compound annual growth rate of 20.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 14, 2025 | 101.99B | -25.20% |
| Dec 31, 2024 | 136.34B | -1.54% |
| Dec 29, 2023 | 138.48B | -0.20% |
| Dec 30, 2022 | 138.76B | -0.30% |
| Dec 31, 2021 | 139.18B | 8.03% |
| Dec 31, 2020 | 128.84B | 2.94% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pro Medicus | 30.13B |
| Cochlear | 18.15B |
| Sonic Healthcare | 10.66B |
| Ramsay Health Care | 7.34B |
| Telix Pharmaceuticals | 5.11B |
| Ansell | 4.73B |
| Mesoblast | 3.70B |
| Neuren Pharmaceuticals | 2.70B |